65,437 trials
Papillomavirus Infections
Primary: Seroconversion Percentages for the HPV Types 6, 11, 16, 18, 31, 33, 45, 52, and 58 — 100.0; 100.0; 100.0; 100.0 Percentage of Participants
Physical Activity
Primary: Physical Activity-Steps — 5637.2; 5863.3; 5603.9; 5631.6 Number of steps/day
Hyperkalemia · End Stage Renal Disease
Primary: Total Number of Episodes of Serum Potassium ≥ 5.5 mEq/L — 13; 41 episodes — p=0.024
Heart Failure · Left Bundle-Branch Block · Heart Failure With Reduced Ejection Fraction (HFrEF)
Primary: Clinical Composite Score — 66; 68; 10; 11 Participants — p=0.61
Developmental Language Disorder · Specific Language Impairment · Language Development
Primary: Word Form Recall Accuracy (Number of Words Correctly Recalled) on Expanding and Standard Retrieval Schedules at 5 Mins — 3.93; 6.43; 3.71; 5.21 number of words recalled…
Contraception
Primary: Serum Etonogestrel Concentrations — 0.92 correlation coefficient (r)
Seizures
Primary: Response Ratio (RRatio) — -24.06; -22.45; -25.90; -24.19 RRatio — p==0.986
Alcohol Use Disorder
Primary: Change in Blood Oxygen Level Dependent (BOLD) fMRI Signal for Alcohol Versus Non-alcohol Stimuli — 0.267390; 0.040281; 0.058670; -0.069048 BOLD response
Endometrial Cancer · Uterine Carcinosarcoma
Primary: Treatment Related Overall Response Rate — 30 participants
Non-small Cell Lung Cancer
Primary: The Percentage of Patients That Respond to Treatment — 46; 29 percentage of patients
Vulvodynia · Vulvodynia, Generalized · Vulvar Vestibulitis
Primary: Average Pain Intensity Will be Measured With the Pain Intensity Numbers Scale (PINS). — 3.90; 3.51; 2.48; 2.22 score on a scale — p=0.702
Open Angle Glaucoma · Ocular Hypertension
Primary: Mean IOP Reduction From Time-Matched Baseline at the 8AM and 4PM Time-Points at Week 2, Week 6, and Month 3 — -9.43; -8.85; -8.01; -7.11 mmHg
Glioblastoma Multiforme · Glioma of Brain
Primary: Maximum Tolerated Dose (MTD) — 600; 70 milligrams
Drinking, Alcohol · Drinking Behavior
Primary: Number of Alcoholic Drinks Intended to Consume if They Were Free (i.e., Intensity) — 6.92; 7.33; 6.71 drinks — p=0.97
Colorectal Neoplasms
Primary: Provider Adenoma Detection Rate (for All Colonoscopies) — 52.7; 46.9; 43.5; 42.8 % of colonoscopies w/ 1+ adenomas